We are live on ! Find out more
CA

Continental Advisors Portfolio holdings

AUM $196M
1-Year Est. Return 24.19%
This Fund
S&P 500
This Quarter Est. Return
+5.51%
1 Year Est. Return
+24.19%
3 Year Est. Return
+67.62%
5 Year Est. Return
+60.86%
10 Year Est. Return
+208.23%
AUM
$177M
AUM Growth
-$37.9M
Cap. Flow
-$46.5M
Cap. Flow %
-26.23%
Top 10 Hldgs %
32.63%
Holding
88
New
2
Increased
15
Reduced
37
Closed
15

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.31M
2
VTRS icon
Viatris
VTRS
+$774K
3
IBB icon
iShares Biotechnology ETF
IBB
+$574K
4
B
Barrick Mining
B
+$570K
5
AGN
Allergan plc
AGN
+$554K

Sector Composition

Rank Sector Weight
1 Financials 37.4%
2 Healthcare 23.23%
3 Industrials 2.73%
4 Technology 2.56%
5 Consumer Discretionary 1.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THC icon
51
Tenet Healthcare
THC
$20.1B
$1.37M 0.78%
66,509
+8,000
+14% +$184K
IBB icon
52
CALL
iShares Biotechnology ETF
IBB
$9.31B
$1.33M 0.75%
12,200
-800
-6% -$85.1K
VTRS icon
53
Viatris
VTRS
$20.1B
$1.3M 0.73%
68,179
+35,000
+105% +$774K
GLRE icon
54
Greenlight Captial
GLRE
$563M
$1.23M 0.69%
144,294
-94,377
-40% -$971K
CAH icon
55
CALL
Cardinal Health
CAH
$53.4B
$1.18M 0.66%
25,000
+14,300
+134% +$660K
TD icon
56
PUT
Toronto Dominion Bank
TD
$198B
$1.17M 0.66%
20,000
BSX icon
57
Boston Scientific
BSX
$65.8B
$1.03M 0.58%
24,007
-3,500
-13% -$135K
FBNC icon
58
First Bancorp
FBNC
$2.6B
$985K 0.56%
27,037
-3,689
-12% -$135K
RVSB icon
59
Riverview Bancorp
RVSB
$107M
$856K 0.48%
100,209
-13,678
-12% -$106K
WT icon
60
WisdomTree
WT
$2.97B
$839K 0.47%
135,908
-280,336
-67% -$1.9M
NMIH icon
61
NMI Holdings
NMIH
$3.25B
$823K 0.46%
29,001
-23,051
-44% -$642K
JNJ icon
62
Johnson & Johnson
JNJ
$634B
$766K 0.43%
5,503
BIIB icon
63
Biogen
BIIB
$29.9B
$743K 0.42%
3,177
IBB icon
64
iShares Biotechnology ETF
IBB
$9.31B
$589K 0.33%
+5,400
New +$574K
CYH icon
65
Community Health Systems
CYH
$385M
$566K 0.32%
211,839
CS
66
CALL
DELISTED
Credit Suisse Group
CS
$502K 0.28%
41,900
-21,100
-33% -$257K
MYGN icon
67
Myriad Genetics
MYGN
$530M
$386K 0.22%
13,892
TEVA icon
68
CALL
Teva Pharmaceuticals
TEVA
$35.9B
$369K 0.21%
+40,000
New +$482K
MNK
69
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$368K 0.21%
40,085
WBA
70
DELISTED
Walgreens Boots Alliance
WBA
$292K 0.16%
5,343
HNGR
71
DELISTED
Hanger Inc.
HNGR
$262K 0.15%
13,678
AGN
72
CALL
DELISTED
Allergan plc
AGN
$167K 0.09%
1,000
-4,400
-81% -$609K
BHF icon
73
Brighthouse Financial
BHF
$3.63B
-15,800
Closed -$573K
BKD icon
74
CALL
Brookdale Senior Living
BKD
$3.62B
-32,100
Closed -$211K
DVA icon
75
CALL
DaVita
DVA
$15.1B
-10,700
Closed -$581K

Similar funds

Continental Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Continental Advisors held 88 positions worth $177M, down 18% from $215M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Continental Advisors withdrew a net $46.5M in Q2 2019, closing 15 positions and reducing 37 holdings. Its most notable exit was Avon Products, Inc., an estimated $2.13M position sold in full.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Continental Advisors opened a new position in iShares Biotechnology ETF worth $589K.

  • Continental Advisors's largest Q2 2019 buy was iShares Biotechnology ETF: 5,400 shares worth $589K.
  • Continental Advisors added most to Citigroup in Q2 2019, an estimated $1.31M increase.
  • Continental Advisors's biggest Q2 2019 reduction was WisdomTree, cutting an estimated $1.9M.
  • Continental Advisors fully exited Avon Products, Inc. in Q2 2019, selling an estimated $2.13M.
  • Continental Advisors's ten largest holdings make up 33% of its $177M portfolio in Q2 2019.
  • Continental Advisors opened 2 new positions and closed 15 in Q2 2019.
  • Continental Advisors's portfolio value fell 18% quarter-over-quarter to $177M.

Based on Continental Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.